<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://www.limsforum.com/styles/rss.xsl" ?><?xml-stylesheet type="text/css" href="https://www.limsforum.com/styles/rss.css" ?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Johnson &#038;amp; Johnson, Pfizer, Abbott Labs, GlaxoSmithKline, TSA and More Address Top Challenges in the Transportation &#038;amp; Transfer of Biologics, Addressing Logistics &#038;amp; Distribution, Quality Assurance and Regulatory &#038;amp; Compliance	</title>
	<atom:link href="https://www.limsforum.com/johnson-amp-johnson-pfizer-abbott-labs-glaxosmithkline-tsa-and-more-address-top-challenges-in-the-transportation-amp-transfer-of-biologics-addressing-logistics-amp-distribution/52598/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.limsforum.com/johnson-amp-johnson-pfizer-abbott-labs-glaxosmithkline-tsa-and-more-address-top-challenges-in-the-transportation-amp-transfer-of-biologics-addressing-logistics-amp-distribution/52598/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=johnson-amp-johnson-pfizer-abbott-labs-glaxosmithkline-tsa-and-more-address-top-challenges-in-the-transportation-amp-transfer-of-biologics-addressing-logistics-amp-distribution</link>
	<description>The Global Laboratory, Informatics, Medical and Science Professional Community</description>
	<lastBuildDate>Tue, 28 Sep 2010 22:01:32 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.10</generator>
</channel>
</rss>
